Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Trxade Group stock

Own Trxade Group stock in just a few minutes.

Trxade Group, Inc is a pharmaceutical retailers business based in the US. Trxade Group shares (MEDS) are listed on the NASDAQ and all prices are listed in US Dollars. Trxade Group employs 43 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Trxade Group

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MEDS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Trxade Group share price

Use our graph to track the performance of MEDS stocks over time.

Trxade Group shares at a glance

Information last updated 2021-04-21.
52-week range$4.02 - $8.25
50-day moving average $5.73
200-day moving average $5.73
Wall St. target price$11.50
PE ratio 3255.9639
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.05

Buy Trxade Group shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Trxade Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Trxade Group under- or over-valued?

Valuing Trxade Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Trxade Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Trxade Group's P/E ratio

Trxade Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3256x. In other words, Trxade Group shares trade at around 3256x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Trxade Group's EBITDA

Trxade Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $515,212.

The EBITDA is a measure of a Trxade Group's overall financial performance and is widely used to measure a its profitability.

Trxade Group financials

Revenue TTM $17.1 million
Gross profit TTM $5.7 million
Return on assets TTM -14.49%
Return on equity TTM -39.57%
Profit margin -14.81%
Book value N/A
Market capitalisation $36.3 million

TTM: trailing 12 months

Shorting Trxade Group shares

There are currently 36,420 Trxade Group shares held short by investors – that's known as Trxade Group's "short interest". This figure is 568.7% up from 5,446 last month.

There are a few different ways that this level of interest in shorting Trxade Group shares can be evaluated.

Trxade Group's "short interest ratio" (SIR)

Trxade Group's "short interest ratio" (SIR) is the quantity of Trxade Group shares currently shorted divided by the average quantity of Trxade Group shares traded daily (recently around 95842.105263158). Trxade Group's SIR currently stands at 0.38. In other words for every 100,000 Trxade Group shares traded daily on the market, roughly 380 shares are currently held short.

However Trxade Group's short interest can also be evaluated against the total number of Trxade Group shares, or, against the total number of tradable Trxade Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Trxade Group's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Trxade Group shares in existence, roughly 0 shares are currently held short) or 0.0097% of the tradable shares (for every 100,000 tradable Trxade Group shares, roughly 10 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Trxade Group.

Find out more about how you can short Trxade Group stock.

Trxade Group share dividends

We're not expecting Trxade Group to pay a dividend over the next 12 months.

Have Trxade Group's shares ever split?

Trxade Group's shares were split on a 25:1 basis on 10 August 2008. So if you had owned 1 share the day before before the split, the next day you'd have owned 25 shares. This wouldn't directly have changed the overall worth of your Trxade Group shares – just the quantity. However, indirectly, the new 96% lower share price could have impacted the market appetite for Trxade Group shares which in turn could have impacted Trxade Group's share price.

Trxade Group share price volatility

Over the last 12 months, Trxade Group's shares have ranged in value from as little as $4.02 up to $8.25. A popular way to gauge a stock's volatility is its "beta".

MEDS.US volatility(beta: 1.2)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Trxade Group's is 1.1958. This would suggest that Trxade Group's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Trxade Group overview

Trxade Group, Inc. , together with its subsidiaries, operates a business-to-business (B2B) web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc. ; Community Specialty Pharmacy, LLC; Integra Pharma, LLC; and Other segments. The company operates a web-based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade. com, a web-based pharmaceutical marketplace; InventoryRx.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site